Location History:
- Cambridge, MA (US) (2015 - 2016)
- Richmond, TX (US) (2018 - 2021)
- Rosenberg, TX (US) (2022)
- Nashua, NH (US) (2011 - 2024)
Company Filing History:
15 out of 3,923 
7 out of 25 
2 out of 123 
Years Active: 2011-2025
Title: Troy Douglas Smith: Innovator in Pharmaceutical Research
Introduction
Troy Douglas Smith, an accomplished inventor based in Nashua, NH, has made significant contributions to the field of pharmaceutical research. With a total of 14 patents to his name, he has developed innovative compounds that aim to address critical medical challenges.
Latest Patents
Among his latest patents, two stand out for their potential therapeutic applications. The first patent covers "N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2." This invention relates to specific compounds designed to inhibit the activity of SHP2, a target implicated in various diseases. The second patent is titled "Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors," which includes a compound of formula (I) that is useful for treating BRM-mediated and/or BRG1-mediated diseases or disorders. These inventions reflect his commitment to advancing medical treatments through innovative chemistry.
Career Highlights
Throughout his career, Troy has worked with notable companies in the pharmaceutical industry. He has been associated with Novartis AG, a global healthcare company, and Astex Therapeutics Limited, where his research efforts have contributed to the development of essential therapeutic solutions. His extensive experience in these environments has honed his skills as an inventor, allowing him to create impactful innovations.
Collaborations
Troy's innovative journey has not been a solitary one. He has collaborated with colleagues such as Zhuoliang Chen and Jorge Garcia Fortanet, who have undoubtedly contributed to his research and patent developments. Collaborative efforts are crucial in the field of innovation, as they foster the exchange of ideas and enhance the creativity necessary for breakthroughs.
Conclusion
Troy Douglas Smith exemplifies the spirit of innovation in the pharmaceutical sector. His 14 patents showcase a commitment to solving pressing health issues through creative compound development. As he continues to work alongside esteemed colleagues, the potential for further contributions to medicine remains promising.